Analysis of cost-effectiveness of a new urine-based diagnostic test to diagnose bladder cancer in haematuria patients
3 October 2018
NIHR Leeds MIC researchers have recently published a paper examining the cost effectiveness of a new urine-based diagnostic test, the DCRSHP, as a triage diagnostic tool in diagnosing Urothelial bladder cancer (UBC) in haematuria patients. The new test was compared to cystoscopy which is regarded as the gold standard for bladder cancer detection. The results indicate that the DCRSHP can be both effective and cost-effective if targeted at haematuria patients who are at lower risk of having bladder cancer.
Read the full article here.